No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Sino Medical Sciences Technology Inc. (688108.SH): Products have obtained registration certification in Malaysia.
On March 31, Gelonghui reported that Sino Medical Sciences Technology Inc. (688108.SH) announced that the company submitted the registration application materials for its SC HONKYTONKTM coronary balloon dilation catheter to the Malaysian Medical Devices Authority (MDA) in October 2024. The company recently received notification from the MDA that the registration application materials for the SC HONKYTONKTM coronary balloon dilation catheter have been approved by the MDA.
Express News | Sino Medical Sciences Technology Inc.: The company SC HONKYTONKTM coronary balloon dilation catheter has obtained the registration certificate in Malaysia.
Sano Healthcare: 2025-005: Sano Healthcare Science & Technology Co., Ltd. 2024 Annual Performance Report Announcement
2025-005: Sano Medical Science & Technology Co., Ltd. 2024 Annual Performance Report Announcement
Sales of two centralized procurement products have increased significantly. Sino Medical Sciences Technology Inc. is expected to turn a profit in 2024, and the Brackets are anticipated to obtain registration certification within the year.
① The company's new spiny balloon product also started large-scale sales in 2024, but the admission rate for the spiny balloon is lower than expected; ② The subsidiary Sinopharm ShenChang officially began production in the second quarter of 2023. Due to the short period of production, the capacity utilization rate is relatively low, resulting in higher fixed costs allocated per unit product.
Sino Medical Sciences Technology Inc. (688108): Over a decade of cultivation in the high-end interventional field, innovation boosts performance soaring.
A leader in high-end interventional medical instruments, with substantial technological reserves, initiating coverage for the first time and giving a "Buy" rating. Sino Medical Sciences Technology Inc. is committed to the research and development of high-end interventional medical instruments, with its business covering key areas such as cardiovascular, cerebrovascular, and structural heart diseases, possessing capabilities in coronary and neurology.
